Exagen Inc (XGN) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Exagen Inc.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 66 days, XGN's average price target has gone up $3.25.
Over the past 287 days, XGN's average upside potential has been 50.23%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
XGN Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for XGN as an investment opportunity.
- Exagen Inc's upside potential (average analyst target price relative to current price) is greater than 81.16% of all US stocks.
- Exagen Inc's variance in analysts' estimates is lower than 31.94% of Healthcare stocks.
- Exagen Inc's average analyst price target is greater than 65.32% of stocks in the small market cap category.
- Exagen Inc's number of analysts covering the stock is greater than 36.03% of Healthcare stocks.
Make investment decisions regarding XGN using the data that counts. Try POWR Ratings for free.